InBody Co.,Ltd (KOSDAQ:041830)

Market Cap	590.88B +100.6%
Revenue (ttm)	233.95B +14.4%
Net Income	30.63B -7.6%
EPS	2,422.95 -5.3%
Shares Out	13.34M
PE Ratio	18.28
Forward PE	12.22
Dividend	600.00 (1.35%)
Ex-Dividend Date	Mar 30, 2026

Volume	69,223
Average Volume	109,066
Open	45,000
Previous Close	44,300
Day's Range	41,800 - 45,000
52-Week Range	22,850 - 47,600
Beta	n/a
RSI	71.26
Earnings Date	May 26, 2026

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 1996
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 041830

Financial Performance

In 2025, InBody Co.,Ltd's revenue was 233.95 billion, an increase of 14.42% compared to the previous year's 204.46 billion. Earnings were 30.63 billion, a decrease of -7.57%.